IL137304A - Expanded and genetically modified populations of human hematopoietic stem cells - Google Patents

Expanded and genetically modified populations of human hematopoietic stem cells

Info

Publication number
IL137304A
IL137304A IL13730499A IL13730499A IL137304A IL 137304 A IL137304 A IL 137304A IL 13730499 A IL13730499 A IL 13730499A IL 13730499 A IL13730499 A IL 13730499A IL 137304 A IL137304 A IL 137304A
Authority
IL
Israel
Prior art keywords
stem cells
hematopoietic stem
expanded
genetically modified
human hematopoietic
Prior art date
Application number
IL13730499A
Other languages
English (en)
Other versions
IL137304A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/237,291 external-priority patent/US20030044978A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL137304A0 publication Critical patent/IL137304A0/xx
Publication of IL137304A publication Critical patent/IL137304A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL13730499A 1998-02-05 1999-01-29 Expanded and genetically modified populations of human hematopoietic stem cells IL137304A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1942898A 1998-02-05 1998-02-05
US7683698P 1998-03-04 1998-03-04
US09/237,291 US20030044978A1 (en) 1998-02-05 1999-01-25 Expanded and genetically modified populations of human hematopoietic stem cells
PCT/EP1999/000597 WO1999040180A2 (en) 1998-02-05 1999-01-29 Expanded and genetically modified populations of human hematopoietic stem cells

Publications (2)

Publication Number Publication Date
IL137304A0 IL137304A0 (en) 2001-07-24
IL137304A true IL137304A (en) 2005-09-25

Family

ID=27361219

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13730499A IL137304A (en) 1998-02-05 1999-01-29 Expanded and genetically modified populations of human hematopoietic stem cells

Country Status (10)

Country Link
EP (1) EP1053302B1 (ja)
JP (1) JP2002502599A (ja)
AT (1) ATE314461T1 (ja)
AU (1) AU755344B2 (ja)
CA (1) CA2318819A1 (ja)
DE (1) DE69929174T2 (ja)
ES (1) ES2252932T3 (ja)
IL (1) IL137304A (ja)
NZ (2) NZ505997A (ja)
WO (1) WO1999040180A2 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009650A2 (en) 2000-07-31 2002-02-07 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7547674B2 (en) * 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
AU2001294577A1 (en) 2000-09-21 2002-04-02 Schering Corporation Methods for preparing interferon producing dentitric cells
DE602004031117D1 (de) * 2003-07-06 2011-03-03 Roger Williams Medical Ct Providence Verfahren zur herstellung differenzierter hämatopoetischer zellen zur behandlung von zytopenie
GB0329449D0 (en) * 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
CN1993460A (zh) * 2004-07-12 2007-07-04 索林集团意大利有限公司 用于培养人细胞的装置和方法
KR20070099550A (ko) 2004-10-25 2007-10-09 셀러랜트 세라퓨틱스 인코퍼레이티드 골수형 세포군의 증량 방법 및 그의 용도
US8383095B2 (en) 2006-02-14 2013-02-26 Cellerant Therapeutics, Inc. Methods and compositions for enhancing engraftment of hematopoietic stem cells
US20100310536A1 (en) * 2007-12-05 2010-12-09 Nissan Chemical Industries Limited Method for expanding hematopoietic stem cells using heterocyclic compound
JP5573161B2 (ja) * 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
EP2228434A4 (en) * 2007-12-05 2013-01-23 Nissan Chemical Ind Ltd Amplification method for hematopoietic stem cells with heterocyclic compound
GB0818725D0 (en) 2008-10-13 2008-11-19 Habib Nagy A Pharmaceutical composition
ES2336637B1 (es) * 2009-11-02 2011-01-21 Banc De Sang I Teixits Procedimiento parala expansion indiferenciada u orientada a linaje mieloide de celulas madre hematopoyeticas procedentes de sangre de cordonumbilical, sangre periferica movilizada o medula osea.
ES2773892T3 (es) * 2014-09-18 2020-07-15 Univ Montreal Compuestos y métodos para incrementar la transferencia génica viral en células hematopoyéticas humanas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314644A (en) * 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
US6060052A (en) * 1995-10-30 2000-05-09 Systemix, Inc. Methods for use of Mpl ligands with primitive human hematopoietic stem cells

Also Published As

Publication number Publication date
WO1999040180A3 (en) 1999-10-28
CA2318819A1 (en) 1999-08-12
EP1053302A2 (en) 2000-11-22
IL137304A0 (en) 2001-07-24
ES2252932T3 (es) 2006-05-16
NZ505997A (en) 2003-08-29
AU2721299A (en) 1999-08-23
JP2002502599A (ja) 2002-01-29
DE69929174T2 (de) 2006-08-31
NZ524254A (en) 2004-11-26
WO1999040180A2 (en) 1999-08-12
ATE314461T1 (de) 2006-01-15
AU755344B2 (en) 2002-12-12
DE69929174D1 (de) 2006-02-02
EP1053302B1 (en) 2005-12-28
WO1999040180A9 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
IL137304A0 (en) Expanded and genetically modified populations of human hematopoietic stem cells
Dawson et al. Induction of drug metabolizing enzymes in human liver cell line Hep G2
CA2407505A1 (en) Hepatocyte lineage cells derived from pluripotent stem cells
HU197766B (en) Process for producing cell lines independent of serum
JP2003513664A5 (ja)
CA2388811A1 (en) Techniques for growth and differentiation of human pluripotent stem cells
ATE399855T1 (de) Tierzellkulturmedium mit pflanzlichen nährstoffen
ATE296875T1 (de) Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen
NZ330060A (en) method of culturing hematopoietic cells in a growth media containing human interleukin-3 mutant fusion protein
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
NZ502712A (en) Medium and method for long term culturing of avian primordial germ cells (PGC) in a tissue culture comprising growth factors
Lipsky et al. Accessory cells unrelated to mononuclear phagocytes and not of bone marrow origin
DE60032508D1 (de) VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
Eidam et al. The plateau phase of growth of the LM strain mouse cell in a protein-free medium: I. Patterns of protein and nucleic acid synthesis and turnover
WO2002102971A3 (en) Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
Wullems et al. Transfer of the human genes coding for thymidine kinase and galactokinase to Chinese hamster cells and human-Chinese hamster cell hybrids
Bogenmann et al. Invasive properties of primary pediatric neoplasms in vitro
EP2281892A3 (en) Methods for producing polypeptides in respiratory-deficient Trichoderma cells
WO2004078916A3 (en) In vitro micro-organs, and uses related thereto
EP1270719A3 (en) Cell population containing non-fetal hemangioblasts and method for producing same
URAKAMI et al. Characterization and identification of methanol-utilizing Hyphomicrobium strains and a comparison with species of Hyphomonas and Rhodomicrobium
Birkedal-Hansen et al. Growth and differentiation of an established rat keratinocyte line in serial culture
AU2444997A (en) Method for gene transfer to the central nervous system
Vaz et al. Definition of early progenitors and functional maturation of human natural killer cells: requirements for cytocidal activity

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees